dc.contributor.author |
Padoa, Carolyn J.
|
|
dc.contributor.author |
Rheeder, Paul
|
|
dc.contributor.author |
Pirie, Fraser J.
|
|
dc.contributor.author |
Motala, Ayesha A.
|
|
dc.contributor.author |
Van Dyk, Jacobus C.
|
|
dc.contributor.author |
Crowther, Nigel J.
|
|
dc.date.accessioned |
2020-03-31T11:35:27Z |
|
dc.date.issued |
2020-12 |
|
dc.description.abstract |
AIMS : To compare the age at diagnosis and prevalence of islet autoantibody [glutamic acid decarboxylase (65 kDa) 65 and islet antigen 2] positivity in black and white participants with type 1 diabetes in South Africa, and to analyse the relationship between age at diagnosis and the presence of autoantibodies.
METHODS : Participants were recruited from diabetes outpatient departments and autoantibodies to glutamic acid decarboxylase (65 kDa) and islet antigen 2 were measured by enzyme‐linked immunosorbent assay.
RESULTS : We recruited 472 (353 black and 119 white) participants with type 1 diabetes. Age at diagnosis of diabetes was later in black (19.7 ± 10.5) than in white participants (12.7 ± 10.8 years; P < 0.001) with a median (interquartile range) disease duration of 5.0 (2.0–10.0) and 8.5 (4.0–20.0) years (P < 0.001), respectively. An older age at diagnosis (≥ 21 years) was more frequent in black (152 of 340, 45%) than in white participants (24 of 116, 21%; P < 0.001). The prevalence of islet antigen 2 autoantibodies was 19% (66/352) in black and 41% in white participants (48/118; P < 0.001). There was no significant difference in glutamic acid decarboxylase (65 kDa) autoantibody positivity between black (212/353, 60%) and white participants (77/117, 66%; P = 0.269). In black, but not white, participants the prevalence of both glutamic acid decarboxylase (65 kDa) and islet antigen 2 autoantibody positivity was significantly lower in participants diagnosed at age ≥ 21 years (P < 0.001 for both comparisons).
CONCLUSIONS : The older age at diagnosis, lower prevalence of islet antigen 2 autoantibodies and a distinct subgroup of participants with type 1 diabetes with age at diagnosis of > 20 years in the black compared to white population suggest a difference in the immunological aetiology of type 1 diabetes in these two population groups. |
en_ZA |
dc.description.department |
Internal Medicine |
en_ZA |
dc.description.embargo |
2020-12-06 |
|
dc.description.librarian |
hj2020 |
en_ZA |
dc.description.sponsorship |
The South African Medical Research Council and the National Health Laboratory Service Research Trust (94472). |
en_ZA |
dc.description.uri |
https://onlinelibrary.wiley.com/journal/14645491 |
en_ZA |
dc.identifier.citation |
Padoa, C.J., Rheeder, P., Pirie, F.J. et al. 2020, 'Identification of a subgroup of black South Africans with type 1 diabetes who are older at diagnosis but have lower levels of glutamic acid decarboxylase and islet antigen 2 autoantibodies', Diabetic Medicine, vol. 37, no. 12, pp. 2067-2074. |
en_ZA |
dc.identifier.issn |
0742-3071 (print) |
|
dc.identifier.issn |
1464-5491 (online) |
|
dc.identifier.other |
10.1111/dme.14204 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/73886 |
|
dc.language.iso |
en |
en_ZA |
dc.publisher |
Wiley |
en_ZA |
dc.rights |
© 2019 Diabetes UK. This is the pre-peer reviewed version of the following article : 'Identification of a subgroup of black South Africans with type 1 diabetes who are older at diagnosis but have lower levels of glutamic acid decarboxylase and islet antigen 2 autoantibodies', Diabetic Medicine, vol. 37, no. 12, pp. 2067-2074, 2020, doi : 10.1111/dme.14204. The definite version is available at : https://onlinelibrary.wiley.com/journal/14645491. |
en_ZA |
dc.subject |
Autoantibodies |
en_ZA |
dc.subject |
Black population |
en_ZA |
dc.subject |
GAD65 |
en_ZA |
dc.subject |
IA-2 |
en_ZA |
dc.subject |
Older age at diagnosis |
en_ZA |
dc.subject |
South Africa (SA) |
en_ZA |
dc.subject |
Type 1 diabetes |
en_ZA |
dc.title |
Identification of a subgroup of black South Africans with type 1 diabetes who are older at diagnosis but have lower levels of glutamic acid decarboxylase and islet antigen 2 autoantibodies |
en_ZA |
dc.type |
Postprint Article |
en_ZA |